A 160 patient randomized control study comparing patient self-testing with CoagCare vs. standard care in Cork, Ireland will be completed in April 2008.
 
     
  Articles  
  CoagCare study published in the Journal of Thrombosis and Thrombolysis  
     
  Links  
  www.acforum.org
www.coumadin.com
www.hemosense.com
www.ITCMED.com
 
     
 
  ZyCare's technology is a generic platform that lends itself to the management of many chronic illnesses. In addition to oral anticoagulation therapy with warfarin, ZyCare sees applications of this technology for the management of asthma, heart failure, hypertension and other diseases.  
 
 
 
Fewer visits to the clinic. Stay in contact with your service no matter where you go. Easily manage your therapy.
  learn more>>
 
Safely supervise the management of more patients. Reduce chances of error. Increase uniformity of care.
 
 
  learn more>>
 
 
   
Announcements
CMS recommends expansion of coverage for home INR testing

Now available: Direct connectivity with INR Monitors:

  • » HEMOCHRON® Signature Elite (ITC)
  • » CoaguChek® XS Plus (Roche Diagnostics Corp)
  • » INRatio®
    (HemoSense, Inc.)
Pima Heart selects CoagCare®
General Information

ZyCare welcomes its newest team members.

Dan Kelly
Director

Darryl Landis
Chief Medical Officer

Elliott Sogol
Director Pharmacy Operations and Services

David Garcia
Medical Advisor

  © 2008 ZyCare Inc. All Rights Reserved.